The Global Advanced Empty Capsule market is estimated to reach over USD 3.42 billion by 2030, exhibiting a CAGR of 10.01% during the forecast period.
Advanced Empty Capsules are used to deliver various kinds of drugs without altering their formulation. These capsules are designed so that they do not interfere with any drug formulation and ensure proper drug delivery. Growing incidence of chronic diseases and increasing geriatric population are prominent factors that drive the Advanced Empty Capsule market growth during the forecast period. Moreover, increasing research and development activity in the healthcare sector to advance therapeutics will also provide new opportunities for Advanced Empty Capsule market players worldwide. Rising demand for nutraceuticals is also anticipated to favour Advanced Empty Capsule market growth through 2028.
However, the limited availability of raw materials to manufacture empty capsules is expected to have a restraining effect on the global Advanced Empty Capsule market in the years to come. Social stigma around animal-derived raw materials is also likely to have a restraining effect on the Advanced Empty Capsule market potential over the forecast period. The COVID-19 pandemic also had an adverse impact on the Advanced Empty Capsule market growth trend, but the market is expected to make a good recovery in the post-pandemic world.
The Advanced Empty Capsule market is segmented on the basis of product and application. Based on product, the market is segmented as Oral Capsules (Dry Formulations (Immediate-Release Capsules (Gelatin, HPMC, Starch, Pullulan), Delayed-Release Capsules (Time Delayed-Release Capsules (Gelatin, HPMC), Acid-Resistant Capsules (Gelatin, HPMC, HPMCP), Enteric Capsules (Gelatin, HPMC, HPMC-AS), Liquid formulation (Gelatin, HPMC, Starch, Pullulan)), Inhalation Capsules (Gelatin, HPMC, Starch, Pullulan). By raw materials, the market is segmented into Animal Source (Contract Type-A (Pork SkinT), ype-B Gelatin (Animal Bones & Calf Skin), Fish Bone Gelatin), Vegetarian-based (Hydroxy Propyl Methyl Cellulose (HPMC), Starch, Pullulan). By capsule size, the market is segmented into Size "000" Capsules, Size "00" Capsules, Size "0" Capsules, Size "1" Capsules, Size "2" Capsules, Size "3" Capsules, Size "4" Capsules, Size "5" Capsules. By end users, the market is segmented into Pharmaceutical, Nutraceutical & Cosmetic, CROs, and CMOS.
Based on raw materials, the vegetarian-based segment to gain popularity
The vegetarian-based raw material segment is anticipated to hold a dominant outlook over the forecast period owing to the rising focus on cruelty-free products across the world. Increasing preference for organic and plant-based products among the general population will also strengthen demand in this segment. However, the animal-derived segment is also expected to account for a substantial market share over the coming years.
The Pharmaceutical End-user Industry Dominates the market.
The pharmaceutical industry is augmenting rapidly across the world, and this trend is fueling the demand for pharmaceuticals. The increasing need for new drug delivery systems is expected to boost the use of Advanced Empty Capsule in the pharmaceutical sector over the forecast period. Increasing drug launches and the rising prevalence of chronic diseases will further bolster the growth of this industry over the forecast period.
The North America Advanced Empty Capsule market holds a dominant outlook in the region.
The North America Advanced Empty Capsule market is expected to account for a significant market share and is anticipated to gain a dominant stance across the forecast period. The presence of key pharmaceutical companies, rising research and development activity, increasing demand for drugs, and supportive government initiatives are expected to prominently drive growth in this region through 2028. The United States is anticipated to be the most prominent market in this region due to the rising prevalence of chronic diseases and a growing geriatric population. Increasing focus on healthcare and rising investments in healthcare research will further bolster Advanced Empty Capsule regional market growth.
The key players in the Advanced Empty Capsule market have shifted their focus towards bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Advanced Empty Capsule market are ACG Worldwide, Capsugel (Lonza Group Ltd.), Medi-Caps Ltd., Sunil Healthcare Ltd., Roxlor LLC, Snail Pharma Industry Co. Ltd., CapsCanada Corporation, Suheung Co., Ltd., Bright Pharma Caps Inc., Fuji Capsule Co., Ltd., Comed Chemicals, Erawat Pharma Limited, Evonik, Farmacapsulas, Fortcaps Healthcare, Health Caps India, LFA Machines Oxford, Mitsubishi Chemical Holdings Corporation, Natural Capsules, Nectar Lifesciences, Qingdao Yiqing Medicinal Capsules, Saviour Caps, Shanxi Guangsheng Medicinal Capsule, Shaoxing Kangke Capsule, Shaoxing Zhongya Capsule, Shree Pharma Caps, Suheung, Sunil Healthcare, Zhejiang Yuexi Capsule, and Other Prominent Players.